chr1-153960390-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001271958.2(SLC39A1):c.683G>A(p.Arg228Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000359 in 1,614,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001271958.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC39A1 | NM_001271958.2 | c.683G>A | p.Arg228Gln | missense_variant | 4/4 | ENST00000356205.9 | NP_001258887.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A1 | ENST00000356205.9 | c.683G>A | p.Arg228Gln | missense_variant | 4/4 | 1 | NM_001271958.2 | ENSP00000348535.4 | ||
ENSG00000285779 | ENST00000648921.1 | n.*771G>A | non_coding_transcript_exon_variant | 6/6 | ENSP00000498105.1 | |||||
ENSG00000285779 | ENST00000648921.1 | n.*771G>A | 3_prime_UTR_variant | 6/6 | ENSP00000498105.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000680 AC: 17AN: 250022Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135442
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461672Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 727136
GnomAD4 genome AF: 0.000138 AC: 21AN: 152364Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74516
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2024 | The c.683G>A (p.R228Q) alteration is located in exon 5 (coding exon 3) of the SLC39A1 gene. This alteration results from a G to A substitution at nucleotide position 683, causing the arginine (R) at amino acid position 228 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at